Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Stroke. 2022 Jan 28;53(6):1847–1853. doi: 10.1161/STROKEAHA.121.037438

Table 3:

Multivariate Analyses Showing the Relationship between IVH Expansion and Outcomes

Outcome IVH Expansion No IVH Expansion Unadjusted
OR (95% CI)
P value Adjusted
OR (95% CI)
P value
Modified Rankin Score 4–6 at 6 months1 91 (67.4) 182 (49.9) 2.07 (1.37–3.14) <0.001 1.84 (1.12–3.02) 0.02
Mortality at 6 months1 43 (31.9) 76 (20.9) 1.78 (1.14–2.76) 0.01 1.40 (0.78–2.50) 0.25
Permanent CSF shunt2 24 (17.8) 66 (18.1) 0.97 (0.58–1.64) 0.94 1.02 (0.58–1.80) 0.93

Abbreviations: CI: confidence interval; IVH, intraventricular hemorrhage; OR: odds ratio

P value <0.05 was considered significant

1

Model was adjusted for age, sex, race, diagnostic parenchymal hematoma volume, hematoma location, withdrawal of care, and treatment randomization arm.

2

Model was adjusted for age, sex, race, diagnostic parenchymal hematoma volume, treatment randomization arm, thalamic location, and ventriculostomy output per day.